Correction: Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function (The Journal of Pediatrics (2016) 169 (116–121.e2) (S0022347615009750) (10.1016/j.jpeds.2015.08.042));Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function
Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis
139e131
M.W. Konstan, W.J. Morgan, S.M. Butler, D.J. Pasta, M.L. Craib, S.J. Silva, et al. Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis J Pediatr 151 2007 134 139 139e131
Risk factors for rate of decline in FEV1 in adults with cystic fibrosis
M.W. Konstan, J.S. Wagener, D.R. Vandevanter, D.J. Pasta, A. Yegin, L. Rasouliyan, and et al. Risk factors for rate of decline in FEV1 in adults with cystic fibrosis J Cyst Fibros 11 2012 405 411
Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation
D.B. Sanders, R.C. Bittner, M. Rosenfeld, L.R. Hoffman, G.J. Redding, and C.H. Goss Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation Am J Respir Crit Care Med 182 2010 627 632
Lung function decline from adolescence to young adulthood in cystic fibrosis
S.L. Vandenbranden, A. McMullen, M.S. Schechter, D.J. Pasta, R.L. Michaelis, M.W. Konstan, et al. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis Lung function decline from adolescence to young adulthood in cystic fibrosis Pediatr Pulmonol 47 2012 135 143
Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function
W.J. Morgan, J.S. Wagener, A. Yegin, D.J. Pasta, S.J. Millar, M.W. Konstan Scientific Advisory Group Investigators, Coordinators of the Epidemiologic Study of Cystic Fibrosis Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function J Pediatr 163 2013 1152 1157
Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada
W.J. Morgan, S.M. Butler, C.A. Johnson, A.A. Colin, S.C. FitzSimmons, D.E. Geller, and et al. Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada Pediatr Pulmonol 28 1999 231 241
ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3-95-yr age range: The global lung function 2012 equations
P.H. Quanjer, S. Stanojevic, T.J. Cole, X. Baur, G.L. Hall, B.H. Culver, and et al. ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations Eur Respir J 40 2012 1324 1343
Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis
V. Waters, S. Stanojevic, E.G. Atenafu, A. Lu, Y. Yau, E. Tullis, and et al. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis Eur Respir J 40 2012 61 66
Pulmonary exacerbations in cystic fibrosis: Young children with characteristic signs and symptoms
W.E. Regelmann, M.S. Schechter, J.S. Wagener, W.J. Morgan, D.J. Pasta, E.P. Elkin, and et al. Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms Pediatr Pulmonol 48 2013 649 657
